<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03135431</url>
  </required_header>
  <id_info>
    <org_study_id>17-000898</org_study_id>
    <nct_id>NCT03135431</nct_id>
  </id_info>
  <brief_title>Opportunistic Salpingectomy for Permanent Sterilization at the Time of Cesarean Delivery</brief_title>
  <official_title>Opportunistic Salpingectomy at the Time of Cesarean Delivery: A Randomized Controlled Trial of the Safety of Salpingectomy vs Tubal Ligation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the safety of performing a bilateral tubal ligation
      vs. bilateral salpingectomy, two procedures performed for permanent sterilization, at the
      time of cesarean delivery. The investigators want to determine if performing bilateral
      salpingectomy at the time of cesarean delivery poses any greater risk for blood loss, as
      compared to a bilateral tubal ligation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A non-inferiority, two-arm randomized controlled trial to evaluate the safety and feasibility
      of prophylactic salpingectomy at the time of a cesarean delivery will be conducted as an
      initiative to avoid a missed opportunity in the primary prevention of ovarian cancer. Once
      enrolled and consented, women will be randomized using a stratified block randomization
      algorithm according to number of prior cesarean deliveries and BMI to either salpingectomy or
      bilateral tubal ligation. The data collection will include preoperative CBC, time of
      procedure, postoperative CBC at 24 hours, standard patient demographics, procedural
      complications, estimated blood loss, return to the OR, length of stay, pain scores, and
      postoperative complications, including readmission within 6 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">May 17, 2017</start_date>
  <completion_date type="Anticipated">October 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Two-arm randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean difference between pre and postoperative hemoglobin (g/dl)</measure>
    <time_frame>At least 24 but not greater than 48 hours after surgery</time_frame>
    <description>Identify the mean difference in pre and postoperative hemoglobin for patients undergoing salpingectomy for sterilization vs. patients undergoing standard bilateral tubal ligation via mid-segment resection of the fallopian tube at the time of cesarean delivery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>Day of surgery</time_frame>
    <description>Compare mean difference in length of operative time (in minutes) to perform bilateral salpingectomy as compared to standard bilateral tubal ligation, following cesarean delivery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimated blood loss</measure>
    <time_frame>Day of surgery</time_frame>
    <description>Identify mean difference in estimated total blood loss as a result of standard bilateral tubal ligation surgical procedure and bilateral salpingectomy procedure, following cesarean delivery.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Contraception</condition>
  <arm_group>
    <arm_group_label>Salpingectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bilateral salpingectomy following cesarean delivery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tubal Ligation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bilateral tubal ligation following cesarean delivery via Parkland or modified Pomeroy methods.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bilateral Salpingectomy</intervention_name>
    <description>Surgical removal of entire fallopian tubes</description>
    <arm_group_label>Salpingectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bilateral Tubal Ligation</intervention_name>
    <description>Surgical tying, cutting, or removal of a portion of the fallopian tubes</description>
    <arm_group_label>Tubal Ligation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women

          -  21 years of age or older

          -  Desire permanent sterilization

          -  Scheduled for a Cesarean delivery

        Exclusion Criteria:

          -  Body Mass Index &gt; 50

          -  Emergent, 'alpha' Cesarean delivery

          -  Single ovary/fallopian tube complex
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vanessa E Torbenson, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 27, 2017</study_first_submitted>
  <study_first_submitted_qc>April 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2017</study_first_posted>
  <last_update_submitted>June 11, 2017</last_update_submitted>
  <last_update_submitted_qc>June 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Vanessa Torbenson</investigator_full_name>
    <investigator_title>Consultant Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

